Skip to main content

GeneDx Holdings

GeneDx Holdings Corp is an American genomic testing and clinical diagnostics company specializing in rare disease testing, exome and genome sequencing, and hereditary cancer screening. The company operates advanced clinical genomics laboratories, providing comprehensive diagnostic testing services, genetic interpretation, and actionable genomic data to physicians, hospitals, and clinical researchers globally. Its core business activities encompass clinical genomic sequencing, rare disease diagnostic testing, bioinformatics analysis, and healthcare data services. Revenue is derived primarily from clinical diagnostic testing service fees, genomic sequencing charges, and healthcare institutional partnerships. GeneDx holds a leading market position in clinical exome and genome sequencing and rare disease diagnostics in the United States. The company is headquartered in Stamford, Connecticut, United States, and its common stock trades on the Nasdaq Global Select Market.

4 of the funds FundTelligence covers report a position in GeneDx Holdings.

Legal name
GeneDx Holdings Corp
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Genetic Testing, Molecular Diagnostics, Precision Medicine & Genomics

Funds holding GeneDx Holdings

Loading...